Table 4 Attitudes of physicians towards innovation
| Â | In your opinion, does the high price of a new product implies also better effectiveness? | |||
|---|---|---|---|---|
| Â | Greece | Cyprus | Difference | p-value |
Absolutely | 2.90% | 4.15% | -1.25% | 0.395 |
Enough | 14.99% | 32.64% | -17.65% | 0.000 |
Not really | 49.23% | 55.96% | -6.73% | 0.079 |
Almost not | 10.48% | 4.66% | 5.82% | 0.001 |
Not at all | 22.40% | 2.59% | 19.81% | 0.000 |
| Â | Generally, what do you think about the effectiveness of new drug products in comparison to the older ones already on the market? | |||
| Â | Greece | Cyprus | Difference | p-value |
Clearly more effective | 18.73% | 24.35% | -5.62% | 0.084 |
Rather more effective | 43.62% | 61.14% | -17.52% | 0.000 |
Do not differ significantlly | 30.15% | 14.51% | 15.64% | 0.000 |
Do not differ at all | 7.49% | 0.00% | 7.49% | 0.000 |
| Â | Which sources do you consult in order to get information for the launch of new drugs? | |||
| Â | Greece | Cyprus | Difference | p-value |
Scientific journals | 78.99% | 76.68% | 2.31% | 0.477 |
Medical congresses | 75.10% | 7.25% | 63.85% | 0.000 |
Pharmaceutical representatives | 77.33% | 88.08% | -10.75% | 0.000 |
Scientific medical societies | 38.87% | 51.30% | -12.43% | 0.001 |
Internet | 30.32% | 41.45% | -11.13% | 0.003 |